000301998 001__ 301998
000301998 005__ 20251106153310.0
000301998 0247_ $$2doi$$a10.1016/j.xhgg.2025.100465
000301998 0247_ $$2pmid$$apmid:40495383
000301998 037__ $$aDKFZ-2025-01197
000301998 041__ $$aEnglish
000301998 082__ $$a610
000301998 1001_ $$aMies, Georgia$$b0
000301998 245__ $$aMeta-analysis of uveal melanoma genome-wide association studies identifies novel risk loci and population effect size heterogeneity.
000301998 260__ $$aCambridge, Ma.$$bCell Press$$c2025
000301998 3367_ $$2DRIVER$$aarticle
000301998 3367_ $$2DataCite$$aOutput Types/Journal article
000301998 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1762439539_1579194
000301998 3367_ $$2BibTeX$$aARTICLE
000301998 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000301998 3367_ $$00$$2EndNote$$aJournal Article
000301998 500__ $$aVolume 6, Issue 3, 10 July 2025, 100465
000301998 520__ $$aUveal melanoma (UM) is a rare but frequently metastasizing cancer. Genome-wide association studies have identified three common genome-wide significant germline risk loci. Here, we perform a genome-wide association study on 401 new cases and conduct a meta-analysis with three independent previously published cohorts for a total sample size of 2,426 cases. We confirm the three previously identified risk loci and identify four additional genome-wide significant loci. We find that eye pigmentation decreasing variants are systematically associated with increased UM risk, and that selection for lighter pigmentation in the past 5000 years explains about 73% of the difference in UM incidence between Northern and Southern Europe. We find evidence of effect size heterogeneity at significant loci across cohorts, in particular, a weaker association between eye pigmentation and UM in a Finnish cohort. Finally, we confirm differential effect sizes between uveal melanoma cases with and without loss of chromosome 3, the major determinant of metastatic risk. Our study identifies novel germline risk factors for UM and highlights genetic and environmental heterogeneity in its etiology.
000301998 536__ $$0G:(DE-HGF)POF4-312$$a312 - Funktionelle und strukturelle Genomforschung (POF4-312)$$cPOF4-312$$fPOF IV$$x0
000301998 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000301998 7001_ $$aTsao, Noah L$$b1
000301998 7001_ $$aHouy, Alexandre$$b2
000301998 7001_ $$aCoupland, Sarah E$$b3
000301998 7001_ $$aKalirai, Helen$$b4
000301998 7001_ $$0P:(DE-He78)f26164c08f2f14abcf31e52e13ee3696$$aFörsti, Asta$$b5$$udkfz
000301998 7001_ $$0P:(DE-He78)19b0ec1cea271419d9fa8680e6ed6865$$aHemminki, Kari$$b6$$udkfz
000301998 7001_ $$aThomsen, Hauke$$b7
000301998 7001_ $$aStern, Marc-Henri$$b8
000301998 7001_ $$aShields, Carol L$$b9
000301998 7001_ $$aDamrauer, Scott M$$b10
000301998 7001_ $$aEwens, Katheryn G$$b11
000301998 7001_ $$aGanguly, Arupa$$b12
000301998 7001_ $$aMathieson, Iain$$b13
000301998 773__ $$0PERI:(DE-600)3058157-6$$a10.1016/j.xhgg.2025.100465$$gp. 100465 -$$n3$$p100465$$tHuman genetics and genomics advances$$v6$$x2666-2477$$y2025
000301998 909CO $$ooai:inrepo02.dkfz.de:301998$$pVDB
000301998 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f26164c08f2f14abcf31e52e13ee3696$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000301998 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)19b0ec1cea271419d9fa8680e6ed6865$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000301998 9131_ $$0G:(DE-HGF)POF4-312$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunktionelle und strukturelle Genomforschung$$x0
000301998 9141_ $$y2025
000301998 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bHUM GENET GENOM ADV : 2022$$d2024-12-14
000301998 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-14
000301998 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-14
000301998 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2023-04-12T14:51:28Z
000301998 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2023-04-12T14:51:28Z
000301998 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2023-04-12T14:51:28Z
000301998 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-14
000301998 915__ $$0StatID:(DE-HGF)0112$$2StatID$$aWoS$$bEmerging Sources Citation Index$$d2024-12-14
000301998 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-14
000301998 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-14
000301998 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2024-12-14
000301998 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-14
000301998 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-14
000301998 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-14
000301998 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lB062 Pädiatrische Neuroonkologie$$x0
000301998 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x1
000301998 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lEpidemiologie von Krebs$$x2
000301998 9201_ $$0I:(DE-He78)Z999-20160331$$kZ999$$lErimitus im DKFZ$$x3
000301998 980__ $$ajournal
000301998 980__ $$aVDB
000301998 980__ $$aI:(DE-He78)B062-20160331
000301998 980__ $$aI:(DE-He78)HD01-20160331
000301998 980__ $$aI:(DE-He78)C020-20160331
000301998 980__ $$aI:(DE-He78)Z999-20160331
000301998 980__ $$aUNRESTRICTED